Vanda Pharmaceuticals (VNDA) Change in Account Payables (2010 - 2015)
Vanda Pharmaceuticals (VNDA) reported Change in Account Payables of $142000.0 for Q2 2015, up 120.14% on a YoY basis from $64503.9 in Q2 2014, and down 78.29% sequentially from $654000.0 in Q1 2015.
Vanda Pharmaceuticals (VNDA) Change in Account Payables (2010 - 2015) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 6 years of Change in Account Payables data on file, last reported at $142000.0 in Q2 2015.
- For the quarter ending Q2 2015, Change in Account Payables rose 120.14% year-over-year to $142000.0; the trailing twelve-month figure through Jun 2015 stood at $1.4 million (up 250.49% YoY), and the FY2014 full-year result was $174000.0, down 53.48% from the prior year.
- Change in Account Payables fell to $142000.0 in Q2 2015, from $654000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $909000.0 in Q2 2012 to a low of -$803000.0 in Q4 2012.
- A 5-year average of $54611.1 and a median of $164000.0 in 2011 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables sank 14875.0% in 2012 and jumped 482.41% in 2013, its largest moves.
- Tracing VNDA's Change in Account Payables over 5 years: stood at -$337000.0 in 2011, then sank by 138.28% to -$803000.0 in 2012, then surged by 136.36% to $292000.0 in 2013, then dropped by 1.37% to $288000.0 in 2014, then slumped by 50.69% to $142000.0 in 2015.
- Business Quant data shows VNDA's Change in Account Payables at $142000.0 in Q2 2015, $654000.0 in Q1 2015, and $288000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | 16.86 Mn |
| 10 | Vanda Pharmaceuticals | 312.76 Mn | 110.45 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 142,000.00 |
| Jun 30, 2015 | 142,000.00 |
| Mar 31, 2015 | 654,000.00 |
| Mar 31, 2015 | 654,000.00 |
| Dec 31, 2014 | 288,000.00 |
| Dec 31, 2014 | 288,000.00 |
| Sep 30, 2014 | 299,000.00 |
| Sep 30, 2014 | 299,000.00 |
| Jun 30, 2014 | -705,000.00 |
| Jun 30, 2014 | -705,000.00 |
| Mar 31, 2014 | 292,000.00 |
| Mar 31, 2014 | 292,000.00 |
| Dec 31, 2013 | 292,000.00 |
| Dec 31, 2013 | 292,000.00 |
| Sep 30, 2013 | -798,000.00 |
| Sep 30, 2013 | -798,000.00 |
| Jun 30, 2013 | 54,000.00 |
| Jun 30, 2013 | 54,000.00 |
| Mar 31, 2013 | 826,000.00 |
| Mar 31, 2013 | 826,000.00 |